Nemaura Medical (NASDAQ: NMRD)

Facebooktwitterlinkedinmail

Nemaura Medical (NASDAQ: NMRD)

Nemaura Medical (NASDAQ: NMRD) is a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible glucose trending device designed to provide persons with diabetes and pre-diabetics with an Ambulatory Glucose Profile (AGP) as a superior metric to better manage their blood sugar levels as compared to a HbA1c reading. SugarBEAT® consists of a daily disposable adhesive skin-patch connected to a rechargeable transmitter, with an app displaying glucose readings at five-minute intervals for periods up to 24 hours. SugarBEAT® can additionally be used as an adjunctive Continuous Glucose Monitoring (CGM) device by insulin users when calibrated by a finger stick readin

Facebooktwitterlinkedinmail